Table 5.

Adverse Events/Complications, n (%N) which were designated serious while excluding those events that were definitively not related to trial participation.

	Standard Care N=46	Whole Blood N=40
Transfusion/Hemolytic Reactions	0 (0%)	0 (0%)
Acute Respiratory Distress Syndrome	1 (2.2%)	3 (7.5%)
Cardiac Arrest	6 (13%)	5 (12.5%)
Cerebral Infarction	3 (6.5%)	1 (2.5%)
Deep Vein Thrombosis	3 (6.5%)	1 (2.5%)
Pulmonary Embolus	1 (2.2%)	1 (2.5%)
Rhabdomyolysis	2 (4.3%)	1 (2.5%)
Upper Gastrointestinal Bleeding	1 (2.2%)	0 (0%)
Hyponatremia	1 (2.2%)	0 (0%)
Patients with an Adverse Event	15 (32.6%)	12 (30.0%)